Glucose Health Financials
| GLUC Stock | USD 0.16 0.01 6.67% |
Glucose |
Understanding current and past Glucose Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Glucose Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Glucose Health's assets may result in an increase in income on the income statement.
Please note, the presentation of Glucose Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Glucose Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Glucose Health's management manipulating its earnings.
Glucose Health Stock Summary
Glucose Health competes with Blue Star, A2 Milk, Artisan Consumer, Avi, and A2 Milk. Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas. Glucose Health operates under Packaged Foods classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US3798941080 |
| Business Address | 609 SW 8th |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Benchmark | Dow Jones Industrial |
| Website | www.glucosehealthinc.com |
| Phone | 479 802 3827 |
| Currency | USD - US Dollar |
Glucose Health Key Financial Ratios
Glucose Health's financial ratios allow both analysts and investors to convert raw data from Glucose Health's financial statements into concise, actionable information that can be used to evaluate the performance of Glucose Health over time and compare it to other companies across industries.| Return On Equity | -0.5 | |||
| Return On Asset | -0.28 | |||
| Beta | 3.12 | |||
| Z Score | -33.9 |
Glucose Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Glucose Health's current stock value. Our valuation model uses many indicators to compare Glucose Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Glucose Health competition to find correlations between indicators driving Glucose Health's intrinsic value. More Info.Glucose Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Glucose Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Glucose Health's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Glucose Health Systematic Risk
Glucose Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Glucose Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Glucose Health correlated with the market. If Beta is less than 0 Glucose Health generally moves in the opposite direction as compared to the market. If Glucose Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Glucose Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Glucose Health is generally in the same direction as the market. If Beta > 1 Glucose Health moves generally in the same direction as, but more than the movement of the benchmark.
Glucose Health December 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Glucose Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Glucose Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Glucose Health based on widely used predictive technical indicators. In general, we focus on analyzing Glucose Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Glucose Health's daily price indicators and compare them against related drivers.
| Downside Deviation | 15.44 | |||
| Information Ratio | 0.0564 | |||
| Maximum Drawdown | 77.94 | |||
| Value At Risk | (19.05) | |||
| Potential Upside | 40.0 |
Complementary Tools for Glucose Pink Sheet analysis
When running Glucose Health's price analysis, check to measure Glucose Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glucose Health is operating at the current time. Most of Glucose Health's value examination focuses on studying past and present price action to predict the probability of Glucose Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glucose Health's price. Additionally, you may evaluate how the addition of Glucose Health to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |